Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model.

Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model.


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سعیده راضی صوفیانی , توحید کاظمی , فرزانه لطفی پور بناب , داریوش شانه بندی , سمیه حلاج نژادی , بهزاد برادران

کلمات کلیدی: Gene therapy; IL-12; in vivo;tumor

نشریه: 0 , 44 , 8 , 2016

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله بهزاد برادران
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 59519
عنوان فارسی مقاله Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model.
عنوان لاتین مقاله Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model.
ناشر 7
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق) ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت https://www.ncbi.nlm.nih.gov/pubmed/26759095

خلاصه مقاله
hide/show

Context Immunotherapy is among the most promising modalities for treatment of cancer. Recently, interleukin 12 (IL-12) has been used as an immunotherapeutic agent in cancer gene therapy. IL-12 can activate dendritic cells (DCs) and boost anti-tumor immune responses. Objective In the current study, we have investigated if IL-12 gene therapy can lead to the regression of tumor mass in a mouse model of fibrosarcoma. Material and methods To investigate the therapeutic efficacy of IL-12, WEHI-164 tumor cells were transfected with murine-IL12 plasmids using Lipofectamine. Enzyme linked immunosorbent assay (ELISA) was used to confirm IL-12 expression in transfected cells. The fibrosarcoma mouse model was established by subcutaneous injection of transfected cells to Balb/C mice. Mice were sacrificed and the tumors were extracted. Tumor sizes were measured by caliper. The expression of IL-12 and IFN-g was studied with real-time PCR and western blotting. The expression of Ki-67(a tumor proliferation marker) in tumor mass was studied by immunohistochemistry staining. Results and discussion The group treated with IL-12 showed a significant decrease in tumor mass volume (P: 0.000). The results of real-time PCR and western blotting showed that IL-12 and IFN-g expression increased in the group treated with IL-12 (relative expression of IL-12: 1.9 and relative expression of IFN-g: 1.766). Immunohistochemistry staining showed that Ki-67 expression was reduced in the group treated with IL-12. Conclusion IL-12 gene therapy successfully led to regress of tumor mass in the fibrosarcoma mouse model. This may serve as a candidate therapeutic approach for treatment of cancer.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سعیده راضی صوفیانیاول
توحید کاظمیدوم
فرزانه لطفی پور بنابسوم
داریوش شانه بندیپنجم
سمیه حلاج نژادیششم
بهزاد برادرانهفتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
141-Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma.pdf1395/09/20879908دانلود